InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,659.20
(
0.10%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
-1.63%
)
Bitcoin
60,937.56
(
-3.35%
)
Post# of 160314
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jaybird249

Send PM Follow Ignore
Followers 82
Posts 2822
Boards Moderated 0
Alias Born 05/05/2006

jaybird249

Re: None

Wednesday, 05/11/2011 12:18:49 PM

Wednesday, May 11, 2011 12:18:49 PM

Post# of 160314
DSCO is next IXGN cheapest Biotech on NASDAQ. $3 soon:
-Tiny 21 Million float.

-$27 million cash or $1.1 per share.

-DSCO has resolved manufacturing issues and is ready to file a New Drug Application in a vew months for a drug with a potential $1.8 billion market.
Back out the cash, the market is valuing DSCO at $30 million, the cheapest valuation by miles for any stock with pending drug application.

- The sector is hot and will stay on fire until ASCO.

If you misssed OXGN, DSCO is next.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up